Inventor · disambiguated record
Bruce Mccreedy
Also filed as: MCCREEDY BRUCE · MCCREEDY BRUCE J · MCCREEDY JR BRUCE · MCCREEDY JR BRUCE J
8 granted patents·11 pending applications·851 citations·filing 1999–2024
87Inventor score
Files withMYELOID THERAPEUTICS INC5NEXIMMUNE INC4PREC BIOSCIENCES INC3METABOLON INC2TRIANGLE PHARMACEUTICALS INC2
Top patents by PatentIndex Score
19 records- 0194US11628218B2Engineered chimeric fusion protein compositions and methods of use thereofMYELOID THERAPEUTICS INC·Filed 2022·Granted Apr 18, 2023·3 cites·22 claims
- 0294US6188988B1Systems, methods and computer program products for guiding the selection of therapeutic treatment regimensTRIANGLE PHARMACEUTICALS INC·Filed 2000·Granted Feb 13, 2001·351 cites·66 claims
- 0388US11510981B2Nanoparticle compositions and methods for immunotherapyNEXIMMUNE INC·Filed 2020·Granted Nov 29, 2022·2 cites·19 claims
- 0488US6081786ASystems, methods and computer program products for guiding the selection of therapeutic treatment regimensTRIANGLE PHARMACEUTICALS INC·Filed 1999·Granted Jun 27, 2000·486 cites·66 claims
- 0586US9977034B2Biomarkers for fatty liver disease and methods using the sameMETABOLON INC·Filed 2015·Granted May 22, 2018·5 cites·2 claims
- 0682US10632193B2Nanoparticle compositions and methods for immunotherapyNEXIMMUNE INC·Filed 2015·Granted Apr 28, 2020·4 cites·28 claims
- 0779US11944680B2Engineered chimeric fusion protein compositions and methods of use thereofMYELOID THERAPEUTICS INC·Filed 2023·Granted Apr 2, 2024·0 cites·20 claims
- 0878US2024252630A1Engineered chimeric fusion protein compositions and methods of use thereofMYELOID THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0972US2024066120A1Nanoparticle compositions and methods for immunotherapyNEXIMMUNE INC·Filed 2022·Application pending·0 cites
- 1067US11712477B2Compositions and methods for immunotherapyNEXIMMUNE INC·Filed 2020·Granted Aug 1, 2023·0 cites·14 claims
- 1167US2024327482A1Macrophage specific engager compositions and methods of use thereofMYELOID THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1265US2024139241A1Compositions and methods for conditioning patients for cell therapyMYELOID THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1357US2016129133A1Compositions and methods for immunotherapyNEXIMMUNE·Filed 2014·Application pending·0 cites
- 1455US2018214564A1Compositions and methods for immunotherapyNEXLMMUNE INC·Filed 2018·Application pending·0 cites
- 1553US2023036065A1Methods for cancer immunotherapyPREC BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1653US2022411479A1Cd20 chimeric antigen receptors and methods of use for immunotherapyPREC BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1751US2022273720A1Lymphodepletion dosing regimens for cellular immunotherapiesPREC BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1846US2022047528A1Methods of inhibiting lysine-specific demethylase 1 (lsd-1)SALARIUS PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 1944US2019120855A1Biomarkers for Fatty Liver Disease and Methods Using the SameMETABOLON INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bruce Mccreedy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →